The innate immune resistance implies the constitutive expression of PD-L1, which is driven by intrinsic cellular oncological signalling in tumour cells and can lead to tumour-infiltrating immune cell inhibition [32, 33]. This evidence concerns the gene CD274 and neoplasm.